HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Alloisoleucine, DL-

HCID 99288
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1509-34-8
Standard SMILES
CC[C@@H](C)[C@H](N)C(=O)O
InChIKey
AGPKZVBTJJNPAG-UHNVWZDZSA-N
Molecular formula
C6H13NO2
Average molar mass
131.17 g/mol
Monoisotopic mass
131.09462866

Overview

L-alloisoleucine is an optically active form of alloisoleucine having L-(2S,3R)-configuration. It has a role as a human metabolite. It is an alloisoleucine and a non-proteinogenic L-alpha-amino acid. It is an enantiomer of a D-alloisoleucine. It is a tautomer of a L-alloisoleucine zwitterion.

Names & identifiers

Preferred name
Alloisoleucine, DL-
IUPAC
(2S,3R)-2-amino-3-methylpentanoic acid
English name
L-allo-Isoleucine
Molecular formula
C6H13NO2
Molecular weight
131.17

Names & synonyms

DL-Allo-isoleucineAlloisoleucine, DL-05T3WT3PJ1DL-AlloisoleucineEINECS 221-464-2RefChem:554752L-Alloisoleucine1509-34-8L-allo-IsoleucineAlloisoleucine(2S,3R)-2-amino-3-methylpentanoic acidAllo-Isoleucine
Show more names
L-allo-Ile-OHNSC 206282Brn 1721791H-allo-lle-OHH-L-ALLO-ILE-OHl-alloisoleucin
H-Allo-Ile-OHallo-L-IsoleucineAlloisoleucine, L-(3R)-LS-isoleucine3107-04-8threo-L-IsoleucineL-Norvaline, 3-methyl-, threo-L(+)-Alloisoleucine

Database identifiers

CAS
1509-34-8、3107-04-8、443-79-8
PubChem CID
99288
DTXSID
DTXSID501019679
ChEMBL
CHEMBL56053
ChEBI
CHEBI:43433
UNII
05T3WT3PJ1、6RNR8XN7S2
EC Number
207-139-8、216-142-3、221-464-2

Properties

Computed structural properties

XLogP
-1.7
Topological polar surface area
63.3 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
3
Rotatable bonds
3
Heavy atoms
9
Formal charge
0
Complexity
103

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LogP-1.70
Solubility34.4 mg/mL at 25 °C
Melting Point60 - 64 °C
Physical DescriptionSolid
Collision Cross Section · 2 items

134.45 Ų [M-H]- [CCS Type: DT; Method: stepped-field]

133.4 Ų [M-H]-

Physicochemical properties

Melting point
285 °C · ~285 °C
Boiling point
225.8 · 225.8±23.0 °C(Predicted)
Density
1.293 · 1.2930 (estimate)
refractive index
1.463 · 1.4630 (estimate)
storage temp.
Store at RT.
solubility
Methanol (Slightly, Heated), Water (Slightly, Sonicated)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 3 items

This chemical does not meet GHS hazard criteria for 100% (104 of 104) of all reports.

Not Classified

Aggregated GHS information provided per 104 reports by companies from 1 notifications to the ECHA C&L Inventory.

Hazard information

Regulatory InformationChemical: DL-Alloisoleucine
Other Safety InformationIMAP assessments - DL-Alloisoleucine: Environment tier I assessment
Hazard Classes and CategoriesNot Classified

Safety data

PPE
Eyeshields, Gloves, type N95 (US)
wgk
3
rtecs
BA2933000
hs_code
29224985
Toxicity
rat,LD50,intraperitoneal,6954mg/kg (6954mg/kg),Archives of Biochemistry and Biophysics. Vol. 58, Pg. 253, 1955.
risk_code
36/37/38
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xi
safety_code
26-36
Storage Class
11 - Combustible Solids
Hazard statements
H315-H319-H335
Precautionary statements

Chemistry & industry

Pharmacology

Cellular LocationsCytoplasm
Applications · 1 item

UsesL-alloisoleucine is a stereo-isomer of L-isoleucine (I820175) and is produced as a byproduct of isoleucine via transamination. L-allo-isoleucine has been suggested to induce epithelial β-defensin expression. In addition, L-allo-isoleucine is utilized in the biosynthesis pathway for coronamic acid.

Additional notes · 1 item

DefinitionChEBI: L-alloisoleucine is an optically active form of alloisoleucine having L-(2S,3R)-configuration. It has a role as a human metabolite. It is a non-proteinogenic L-alpha-amino acid and an alloisoleucine. It is an enantiomer of a D-alloisoleucine. It is a tautomer of a L-alloisoleucine zwitterion.

Related reactions

12 records
New reaction record
HRID 55765 reaction equation
HRID 55765As reactant
HRID 398268 reaction equation
HRID 398268As reactant
HRID 640039 reaction equation
HRID 640039As reactant
HRID 1176121 reaction equation
HRID 1176121As reactant
HRID 1274807 reaction equation
HRID 1274807As reactant
HRID 1375192 reaction equation
HRID 1375192As reactant
HRID 1447417 reaction equation
HRID 1447417As reactant
HRID 1486410 reaction equation
HRID 1486410As reactant
PreviousPage 1 of 2

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Nikkaji
J1.239D
form
Powder
pka
2.57 · 2.57±0.24(Predicted)
color
White
optical activity
15.925 · +15.925 (H2O)+39.625 (5 mol dm-3 HCl)
Water Solubility
28.18 g/L · 28.18g/L(20 ºC)
BRN
1721791 · 1721791
InChI
1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5+/m1/s1
InChIKey
AGPKZVBTJJNPAG-UHNVWZDZSA-N
SMILES
CC[C@@H](C)[C@H](N)C(O)=O
CAS DataBase Reference
1509 · 1509-34-8(CAS DataBase Reference)
FDA UNII
6 RNR8XN7S2 · 6RNR8XN7S2
UNSPSC Code
12352209 · 12352209
NACRES
26 · NA.26
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
315 · H315-H319-H335
Precautionary statements
264 · P264-P280-P302+P352-P321-P332+P313-P362-P305+P351+P338-P337+P313-P261-P271-P304+P340-P312-P403+P233-P405-P501
PPE
95 · Eyeshields, Gloves, type N95 (US)
Hazard Codes
Xi
Risk Statements
36 · 36/37/38
Safety Statements
26 · 26-36
WGK Germany
3 · 3
RTECS
2933000 · BA2933000
HS Code
29224985 · 29224985
Storage Class
11 · 11 - Combustible Solids
Toxicity
50 · rat,LD50,intraperitoneal,6954mg/kg (6954mg/kg),Archives of Biochemistry and Biophysics. Vol. 58, Pg. 253, 1955.
P264-P280-P302+P352-P321-P332+P313-P362-P305+P351+P338-P337+P313-P261-P271-P304+P340-P312-P403+P233-P405-P501